Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Allen

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of Child and Adolescent Psychopharmacology|July 17, 2007
Commentary by a child psychiatrist in industry on the assessment of drug safetyAlbert J Allen
The Journal of Clinical Psychiatry|February 4, 2003
Drug development process for a product with a primary pediatric indicationAlbert J Allen, David Michelson
American Family Physician|June 2, 2005
Atomoxetine in the treatment of patients with ADHDJan A Gerbers, Albert J Allen
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2009
Challenges and opportunities in bringing new medications to market for pediatric patientsHimanshu P Upadhyaya, Laura Gault, Albert J Allen
Journal of the American Academy of Child and Adolescent Psychiatry|April 22, 2005
Atomoxetine and tics in ADHDPeter D Feldman, Dustin D Ruff, Albert J Allen
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placeboSitra Tauscher-Wisniewski, Mary Nilsson, Cathy Caldwell, et al.
Child and Adolescent Psychiatry and Mental Health|October 2, 2007
Baseline values from the electrocardiograms of children and adolescents with ADHDSuyash Prasad, Amanda J Furr, Shuyu Zhang, et al.
AJOB Empirical Bioethics|January 8, 2016
A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback SurveyLuann E Van Campen, Albert J Allen, Susan B Watson, et al.
Sleep|January 27, 2007
Effects of atomoxetine and methylphenidate on sleep in children with ADHDR Bart Sangal, Judith Owens, Albert J Allen, et al.
Paediatric Drugs|July 11, 2012
Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislationJohn A Vernon, Scott H Shortenhaus, Mark H Mayer, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of Child and Adolescent Psychopharmacology|July 17, 2007
Commentary by a child psychiatrist in industry on the assessment of drug safetyAlbert J Allen
The Journal of Clinical Psychiatry|February 4, 2003
Drug development process for a product with a primary pediatric indicationAlbert J Allen, David Michelson
American Family Physician|June 2, 2005
Atomoxetine in the treatment of patients with ADHDJan A Gerbers, Albert J Allen
Journal of the American Academy of Child and Adolescent Psychiatry|October 27, 2009
Challenges and opportunities in bringing new medications to market for pediatric patientsHimanshu P Upadhyaya, Laura Gault, Albert J Allen
Journal of the American Academy of Child and Adolescent Psychiatry|April 22, 2005
Atomoxetine and tics in ADHDPeter D Feldman, Dustin D Ruff, Albert J Allen
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placeboSitra Tauscher-Wisniewski, Mary Nilsson, Cathy Caldwell, et al.
Child and Adolescent Psychiatry and Mental Health|October 2, 2007
Baseline values from the electrocardiograms of children and adolescents with ADHDSuyash Prasad, Amanda J Furr, Shuyu Zhang, et al.
AJOB Empirical Bioethics|January 8, 2016
A Pharmaceutical Bioethics Consultation Service: Six-Year Descriptive Characteristics and Results of a Feedback SurveyLuann E Van Campen, Albert J Allen, Susan B Watson, et al.
Sleep|January 27, 2007
Effects of atomoxetine and methylphenidate on sleep in children with ADHDR Bart Sangal, Judith Owens, Albert J Allen, et al.
Paediatric Drugs|July 11, 2012
Measuring the patient health, societal and economic benefits of US pediatric therapeutics legislationJohn A Vernon, Scott H Shortenhaus, Mark H Mayer, et al.
Pageof 6